The embryo's cystatin C and F expression functions as a protective mechanism against the maternal proteinase cathepsin S in mice.
A successful implantation of a mammalian embryo into the maternal endometrium depends on a highly synchronized fetal-maternal dialogue involving chemokines, growth factors, and matrix-modifying enzymes. A growing body of evidence suggests an important role for proteinases playing a role in matrix degeneration and enhancing the embryo's invasive capacity and influencing the mother's immunological status in favor of the conceptus. This study focused on the expression of cathepsin S (CTSS) and its inhibitors in the murine fetal-maternal interface as well as the detection of the cellular sources of either proteinase and inhibitors. Nested RT-PCR for detection of embryonic mRNAs, immunohistochemistry of maternal and fetal tissues in B6C3F1 mice, and FACS analysis for determination of immunocompetent cell population were applied. This study shows that the cysteine proteinase CTSS is upregulated in the stroma of the implantation site, and that pregnancy induces an influx of CTSS-positive uterine natural killer cells. Compared to maternal tissues, the CTSS inhibitors cystatin F and C, but not the proteinase itself, are expressed in blastocysts. In conclusion, CTSS underlies a hormonal regulation in the maternal tissue and therewith most likely supports the embryonic implantation. The invading embryo regulates the depth of its own invasion through the expression of the cathepsin inhibitors and furthermore, interleukin-6 to activate CTSS in maternal tissues. Additionally, the observed decrease in CD3(+) cells leads to the hypothesis that cells of the cytotoxic T-cell group are down-regulated in the decidua to support the implantation and ensure the survival of the embryo.
Baston-Buest
D M
DM
Department of OB/GYN and REI (UniKiD) Department for Hematology, Oncology and Clinical Immunology Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Center University of Dusseldorf, Moorenstrasse 5, 40225 Dusseldorf, Germany.
Schanz
A
A
Buest
S
S
Fischer
J C
JC
Kruessel
J S
JS
Hess
A P
AP
D000818:Animals; D002403:Cathepsins / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000502:physiology; D055316:Cystatin C / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D015891:Cystatins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D019610:Cytoprotection / Q000235:genetics*; D010064:Embryo Implantation / Q000235:genetics; D004622:Embryo, Mammalian / Q000378:metabolism* / Q000502:physiology; D047108:Embryonic Development / Q000235:genetics; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000502:physiology; D033261:Maternal-Fetal Relations; D051379:Mice; D008810:Mice, Inbred C57BL; D011247:Pregnancy
D055316:Cystatin C; D015891:Cystatins; C550521:cystatin F, mouse; D002403:Cathepsins; C028217:cathepsin S